Market revenue in 2023 | USD 242.6 million |
Market revenue in 2030 | USD 403.7 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 69% in 2024. Horizon Databook has segmented the North America bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The bronchial biopsy devices market in North America is expected to witness significant growth, driven by increasing respiratory disease prevalence, technological advancements, and a shift toward disposable devices for enhanced safety. As healthcare providers continue to adopt innovative diagnostic tools, the market is expected to expand, providing opportunities for established players and new entrants.
In addition, the rising prevalence of lung cancer in North America is one of the major factors expected to boost the bronchial biopsy devices market. According to data released by the CDC in June 2024, around 209,500 new cases of lung cancer were reported in the U.S. in 2021.
Moreover, an increase in chronic respiratory conditions, such as Chronic Obstructive Pulmonary Disease (COPD) and interstitial lung diseases, contributes to the demand for bronchial biopsies for diagnostic & management purposes, thereby driving market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America bronchial biopsy devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account